178 related articles for article (PubMed ID: 14746678)
1. [Results and suggestion from comparing between world excellent protocols of childhood acute lymphoblastic leukemia].
Fu RY; Liao QK; Jia CS
Zhonghua Er Ke Za Zhi; 2003 Jul; 41(7):515-9. PubMed ID: 14746678
[No Abstract] [Full Text] [Related]
2. Impact of early intensive reinduction therapy on event-free survival in children with low-risk acute lymphoblastic leukemia.
Henze G; Fengler R; Reiter A; Ritter J; Riehm H
Haematol Blood Transfus; 1990; 33():483-8. PubMed ID: 2182441
[No Abstract] [Full Text] [Related]
3. Benign intracranial hypertension in association with acute lymphoblastic leukemia.
Sastry J; Karandikar SS; English MW
Pediatr Hematol Oncol; 2003 Mar; 20(2):157-60. PubMed ID: 12554527
[No Abstract] [Full Text] [Related]
4. Treatment of high-risk acute lymphoblastic leukemia with protocols PETHEMA LAL 7/78 and LAL 17/84.
Ortega JJ; Javier G; Olivé T
An Esp Pediatr; 1988 Oct; 29 Suppl 34():72-83. PubMed ID: 3214043
[No Abstract] [Full Text] [Related]
5. Minimal residual disease-guided therapy in childhood acute lymphoblastic leukemia.
Campana D; Pui CH
Blood; 2017 Apr; 129(14):1913-1918. PubMed ID: 28167658
[No Abstract] [Full Text] [Related]
6. Treatment of acute lymphoblastic leukemia French protocol Fralle 83-87.
Schaison G; Sommelet D; Bancillon A; Perel Y; Leblanc T; Bergeron C; Lejars O; Baruchel A; Lepage E; Leverger G
Leukemia; 1992; 6 Suppl 2():148-52. PubMed ID: 1578919
[No Abstract] [Full Text] [Related]
7. Long-term outcome of treatment with protocols AL841, AL851, and ALHR88 in children with acute lymphoblastic leukemia: results obtained by the Kyushu-Yamaguchi Children's Cancer Study Group.
Matsuzaki A; Ishii E; Nagatoshi Y; Eguchi H; Koga H; Yanai F; Inada H; Nibu K; Tamai Y; Akiyoshi K; Nakayama H; Hara T; Take H; Miyazaki S; Okamura J
Int J Hematol; 2001 Apr; 73(3):369-77. PubMed ID: 11345205
[TBL] [Abstract][Full Text] [Related]
8. [Treatment of acute lymphoblastic leukemia in children. Results of the FRALLE 83 protocol].
Bancillon A
Arch Fr Pediatr; 1991 Oct; 48(8):593-4. PubMed ID: 1768205
[No Abstract] [Full Text] [Related]
9. [The programmed therapy of acute lymphoblastic leukemia in adults].
Isaev VG; Savchenko VG; Kucher RA; Abakumov EM; Parovichnikova EN
Ter Arkh; 1992; 64(8):82-7. PubMed ID: 1440405
[No Abstract] [Full Text] [Related]
10. [Acute lymphoblastic leukemia in children with initial leucocytosis above 50,000/mm3: summary of treatment results of Polish Pediatric Leukemia/Lymphoma Study Group].
Skoczeń S; Balwierz W; Moryl-Bujakowska A; Pawińska K; Luszczyńska A; Balcerska A; Płoszyńska A; Chybicka A; Dobaczewski G; Juszczak K; Wachowiak J; Derwich K; Kowalczyk J; Wiśniewska-Slusarz H; Matysiak M; Krauze A; Pawelec K; Sońta-Jakimczyk D; Tomaszewska R; Wysocki M; Styczyńskii J; Swiatkiewicz V;
Przegl Lek; 2006; 63(1):11-4. PubMed ID: 16892892
[TBL] [Abstract][Full Text] [Related]
11. [Consolidating chemotherapy in the treatment program of acute lymphoblastic leukemia in children].
Maiakova SA; Makhonova LA
Vestn Akad Med Nauk SSSR; 1986; (5):15-7. PubMed ID: 3487897
[No Abstract] [Full Text] [Related]
12. Lymphoblastic lymphoma of childhood and the LSA2-L2 protocol: the 30-year experience at Memorial-Sloan-Kettering Cancer Center.
Mora J; Filippa DA; Qin J; Wollner N
Cancer; 2003 Sep; 98(6):1283-91. PubMed ID: 12973853
[TBL] [Abstract][Full Text] [Related]
13. The F-MACHOP regimen in advanced diffuse aggressive lymphomas: summary of ten years' experience at a single institution.
Guglielmi C; Amadori S; Martelli M; Papa G; Mandelli F
Leukemia; 1991; 5 Suppl 1():102-4. PubMed ID: 1890858
[No Abstract] [Full Text] [Related]
14. Ten years' experience with LSA2-L2 therapy for childhood advanced lymphoblastic lymphoma.
Katz JA; Hvizdala E; Shuster J; Falletta JM; Schwenn M; Murphy SB
J Clin Oncol; 1993 Oct; 11(10):2054-5. PubMed ID: 8410135
[No Abstract] [Full Text] [Related]
15. Poor outcome of intensive chemotherapy for adult acute lymphoblastic leukemia: a possible dose effect.
Chiu EK; Chan LC; Liang R; Lie A; Kwong YL; Todd D; Chan TK
Leukemia; 1994 Sep; 8(9):1469-73. PubMed ID: 8090027
[TBL] [Abstract][Full Text] [Related]
16. [Treatment of acute lymphoblastic leukemia in adults as an unsolved problem].
Savchenko VG; Parovichnikova EN; Isaev VG; Kulimova EP; Kucher RA; Sokolov AN; Ustinova EN; Gribanova EO; Khoroshko ND; Pivnik AV; Tikhonova LIu; Sarkisian GP; Domracheva EV; Maslova ER; Konstantinova TS; Rekhtman GB; Lapin VA; Miliutina TI
Ter Arkh; 2001; 73(7):6-15. PubMed ID: 11523412
[No Abstract] [Full Text] [Related]
17. Prognostic impact of age in children and adolescents with acute lymphoblastic leukemia: data from the trials ALL-BFM 86, 90, and 95.
Möricke A; Zimmermann M; Reiter A; Gadner H; Odenwald E; Harbott J; Ludwig WD; Riehm H; Schrappe M
Klin Padiatr; 2005; 217(6):310-20. PubMed ID: 16307416
[TBL] [Abstract][Full Text] [Related]
18. Retrospective analysis of late intensification therapy with high-dose methotrexate for standard-risk acute lymphoblastic leukemia in childhood (CCLSG-S811 study). The Children's Cancer and Leukemia Study Group.
Koizumi S; Fujimoto T; Sasaki K; Takeda T; Utsumi J; Mimaya J; Ohta S; Ninomiya T; Takaue Y
Int J Hematol; 1991 Aug; 54(4):307-13. PubMed ID: 1777605
[TBL] [Abstract][Full Text] [Related]
19. [Use of the O6-Paris-LA-66 program in the treatment of patients with lymphoblastic leukemia under 20 years of age].
Mendeleev IM; Arkavina EA; Berliner GB; Polezhaev IuN
Gematol Transfuziol; 1985 Jul; 30(7):15-9. PubMed ID: 3863772
[No Abstract] [Full Text] [Related]
20. [Second cessation of therapy in children with acute lymphoblastic leukemia].
Rokicka-Milewska R; Derulska D; Jackowska T; Armata J; Balwierz W; Bogusławska-Jaworska J; Chybicka A; Cyklis R; Duczmal B; Jakowicka M
Acta Haematol Pol; 1992; 23(1):43-7. PubMed ID: 1615750
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
